– USA, MD – Medcura Inc., today announced the appointment of Jacob Rodman to its Board of Directors.
About Jacob Rodman
Jacob Rodman is the CEO of Raleigh Neurosurgical Clinic, Inc., and the president-elect of Nerves (Neurosurgery Executives Resource Value & Education Society).
Jacob Rodman said, “It is a privilege to serve on Medcura’s Board of Directors. LifeGel has the potential to reshape the spine surgery hemostasis market. Given its impactful FDA breakthrough designation, substantially less cost, and antimicrobial features, we believe LifeGel will become the new standard of care to stop bleeding in spine surgery procedures.”
About Medcura, Inc.
Medcura, Inc. is a leading medical device industry force dedicated to advancing hemostatic solutions for surgical, medical, and consumer markets. Leveraging a proprietary technology platform, Medcura combines the utilization of safe, inert ingredients with groundbreaking chemistries to develop versatile and effective products. Their innovative solutions effectively manage bleeding across diverse clinical applications, providing cost-effective and reliable outcomes.
For more information: https://www.medcurainc.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.